BioNTech SE Sees IPO Range of $18-$20/ADS
September 24 2019 - 6:10AM
Dow Jones News
By Chris Wack
BioNTech SE said in a filing Tuesday it is planning on selling
American Depositary Shares in its initial public offering for an
expected $18 to $20 an ADS.
The Germany-based oncology treatment company said it would sell
13.2 million ADSs, while granting the underwriters the option of
buying 1.98 million ADSs. BioNTech said to date it has raised $1.3
billion of capital in private placements and from its
collaborators, which include Genentech, Sanofi, Genmab, Genevant
Sciences, Eli Lilly, Bayer AG and Pfizer.
For the first six months of 2019, BioNTech said it had revenue
from contracts with customers of 51.9 million euros, compared to
EUR43.4 million in the same period a year earlier. The company
reported a loss for the first half of 2019 of EUR90.7 million,
compared to 2018's loss of EUR23.3 million.
BioNTech said it plans on listing its ADSs on the Nasdaq under
the symbol BNTX.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
September 24, 2019 06:55 ET (10:55 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2024 to May 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From May 2023 to May 2024